{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:20:00Z","timestamp":1790688000744,"version":"4.1.0"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,3,28]]},"DOI":"10.18632\/oncotarget.14903","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T18:02:58Z","timestamp":1485885778000},"page":"20802-20812","source":"Crossref","is-referenced-by-count":11,"title":["Understanding PSA and its derivatives in prediction of tumor volume: addressing health disparities in prostate cancer risk stratification"],"prefix":"10.18632","volume":"8","author":[{"given":"Felix M.","family":"Chinea","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, USA"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Lyapichev","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Epstein","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Urology, and Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deukwoo","family":"Kwon","sequence":"additional","affiliation":[{"name":"Biostatistics, University of Miami Miller School of Medicine, Miami, FL, USA"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Taylor Smith","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Pollack","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, USA"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Cote","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA"},{"name":"Biochemistry, University of Miami Miller School of Medicine, Miami, FL, USA"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr N.","family":"Kryvenko","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA"},{"name":"Urology, University of Miami Miller School of Medicine, Miami, FL, USA"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,1,30]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3322\/caac.21173","article-title":"Cancer statistics for African Americans, 2013","volume":"63","author":"Jemal","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.urolonc.2014.04.014","article-title":"Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer","volume":"32","author":"Lathan","year":"2014","journal-title":"Urol Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.urology.2014.05.009","article-title":"Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups","volume":"84","author":"Kim","year":"2014","journal-title":"Urology"},{"key":"4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.urology.2013.12.054","article-title":"Biopsy criteria for determining appropriateness for active surveillance in the modern era","volume":"83","author":"Epstein","year":"2014","journal-title":"Urology"},{"key":"5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.juro.2013.06.021","article-title":"Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men","volume":"191","author":"Schaeffer","year":"2014","journal-title":"J Urol"},{"issue":"195","key":"6","first-page":"301","article-title":"African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance","volume":"2016","author":"Epstein","journal-title":"J Urol"},{"key":"7","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.juro.2011.12.082","article-title":"Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance","volume":"187","author":"Manoharan","year":"2012","journal-title":"Journal of Urology"},{"key":"8","volume-title":"U.S. Population Projections: 2005-2050. Social and Demographic Trends","author":"Cohn","year":"2008"},{"key":"9","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archinte.162.17.1985","article-title":"Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study","volume":"162","author":"Edwards","year":"2002","journal-title":"Archives of Internal Medicine"},{"key":"10","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/PAS.0000000000000656","article-title":"Radical prostatectomy outcome in White Hispanic\/Latino men with NCCN very low-risk prostate cancer detected by template biopsy","volume":"40","author":"Jorda","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.eururo.2014.10.010","article-title":"Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification","volume":"67","author":"Roobol","year":"2015","journal-title":"European Urology"},{"key":"12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","article-title":"Early detection of prostate cancer: AUA Guideline","volume":"190","author":"Zietman","year":"2013","journal-title":"Journal of Urology"},{"key":"13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1040-8428(03)00094-5","article-title":"Relationship between Prostatic Specific Antigen (PSA) and volume of the prostate in the Benign Prostatic Hyperplasia in the elderly","volume":"47","author":"Fabris","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"14","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.298.19.2275","article-title":"Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer","volume":"298","author":"Moul","year":"2007","journal-title":"JAMA"},{"key":"15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.urology.2015.11.042","article-title":"Prostate-specific Antigen Mass Density-A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution","volume":"90","author":"Epstein","year":"2016","journal-title":"Urology"},{"key":"16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/pros.22928","article-title":"Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens","volume":"75","author":"Kryvenko","year":"2015","journal-title":"Prostate"},{"key":"17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-5347(17)37393-7","article-title":"Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer","volume":"147","author":"Cooner","year":"1992","journal-title":"Journal of Urology"},{"key":"18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1309\/AJCPQL9MKQ6VDDWL","article-title":"Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass","volume":"144","author":"Diaz","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer","volume":"271","author":"Brendler","year":"1994","journal-title":"JAMA"},{"issue":"196","key":"20","first-page":"1659","article-title":"Do Black NonHispanic Men Produce Less Prostate Specific Antigen in Benign Prostate Tissue or Cancer Compared to White NonHispanic Men with Gleason Score 6 (Grade Group 1) Prostate Cancer?","volume":"2016","author":"Cote","journal-title":"J Urol"},{"key":"21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.ju.0000074707.49775.46","article-title":"Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men","volume":"170","author":"Goluboff","year":"2003","journal-title":"Journal of Urology"},{"key":"22","unstructured":"2015. Cancer Facts & Figures for Hispanics\/Latinos 2015-2017. Atlanta, American Cancer Society: American Cancer Society."},{"key":"23","unstructured":"2006. F as in Fat: how obesity policies are failing America. Washington, DC, Trust for America's Health."},{"key":"24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0046-8177(92)90108-F","article-title":"Histologic grading of prostate cancer: a perspective","volume":"23","author":"Gleason","year":"1992","journal-title":"Hum Pathol"},{"key":"25","first-page":"60","article-title":"Patterns of progression in prostate cancer","volume":"1","author":"Stamey","year":"1986","journal-title":"Lancet"},{"key":"26","volume-title":"Cancer in Florida Hispanics 1989-2006","author":"Lee","year":"2010"},{"key":"27","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0022-5347(17)35302-8","article-title":"Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer","volume":"151","author":"Scardino","year":"1994","journal-title":"Journal of Urology"},{"issue":"196","key":"28","first-page":"1664","article-title":"Definition of Insignificant Tumor Volume of Gleason Score 3 + 3 = 6 (Grade Group 1) Prostate Cancer at Radical Prostatectomy-Is it Time to Increase the Threshold?","volume":"2016","author":"Epstein","journal-title":"J Urol"},{"key":"29","first-page":"244","article-title":"The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System","volume":"40","author":"Grading","journal-title":"American Journal Surgical Pathology"},{"issue":"140","key":"30","first-page":"1140","article-title":"Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System","volume":"2016","author":"Epstein","journal-title":"Arch Pathol Lab Med"},{"key":"31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/1066896915600519","article-title":"Average Weight of Seminal Vesicles: An Adjustment Factor for Radical Prostatectomy Specimens Weighed With Seminal Vesicles","volume":"23","author":"Kryvenko","year":"2015","journal-title":"International Journal Surgical Pathology"},{"key":"32","unstructured":"2011. NAACCR Guideline for Enhancing Hispanic\/Latino Identification: Revised NAACCR Hispanic\/Latino Identificaton Algorithm [NHIA v2.2.1]. In: Group NRaEW, ed. Springfield (IL), North American Association of Central Cancer Registries."}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:54:48Z","timestamp":1594832088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,30]]},"references-count":32,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017,3,28]]}},"alternative-id":["14903","28160549"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14903","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,30]]}}}